Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Novopharm Biotech's hMAb enters phase I in Canada

Dec. 19, 1997

No Comments

Seragen reports preliminary results of pivotal CTCL study

Dec. 17, 1997

No Comments

Phase II results reported for Bexxar

Dec. 15, 1997

No Comments

Cel-Sci expands Multikine trial

Dec. 12, 1997

No Comments

New data on PDL's SMART M195 antibody reported

Dec. 12, 1997

No Comments

FDA approves Neoprobe's IND for RIGS/ACT therapy

Dec. 11, 1997

No Comments

ImmunoGen's C242-DM1 found safe in preclinical studies

Dec. 10, 1997

No Comments

ImClone and Merck KGaA expand collaboration for BEC2 cancer vaccine

Dec. 10, 1997

No Comments

Ono-4007: antitumor lipid A analogue that enhances TNF production by macrophages

Dec. 10, 1997

No Comments

StressGen prepares to evaluate Oncocine in clinical trials

Dec. 9, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Immuno-oncology, BioWorld Science
RSS

Novopharm Biotech's hMAb enters phase I in Canada

Seragen reports preliminary results of pivotal CTCL study

Phase II results reported for Bexxar

Cel-Sci expands Multikine trial

New data on PDL's SMART M195 antibody reported

FDA approves Neoprobe's IND for RIGS/ACT therapy

ImmunoGen's C242-DM1 found safe in preclinical studies

ImClone and Merck KGaA expand collaboration for BEC2 cancer vaccine

Ono-4007: antitumor lipid A analogue that enhances TNF production by macrophages

StressGen prepares to evaluate Oncocine in clinical trials

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Cell mapping yields clues to metabolic health in obese individuals

Ionis notches Arrowhead win; Tryngolza cleared for FCS

Immuno-oncology, BioWorld Science RSS

Immuno-oncology, BioWorld Science
RSS